Abstract:Our objective was to develop an array of alpha(7)-selective nicotinic cholinergic receptor (nAChR)-based imaging agents for PET and SPECT. Methods: (2'R)-N-C-11-Methyl-N-(phenylmethyl)-spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridin]-5'-amine 1 was synthesized by reaction of the corresponding desmethyl precursor with C-11-CO2 and reduction. N-(R)-1-Aza-bicyclo[2.2.2]oct-3-yl-4-C-11-methylsulfanyl-benzamide 2 was synthesized by reduction of the corresponding disulfide precursor and reaction with C-11-iodomethane. N-(R)-1-Aza-bicyclo[2.2.2]oct-3-yl-4-'251-iodo-benzamide 3 was synthesized by halogen exchange of the corresponding bromide. (2'R)-5'-(2-I-125-iodo-3-furanyl)spiro[1-azabicyclo[2.2.2] octane]-3,2'(3'H)-furo[2,3-b]pyridine 4 was synthesized by the chloramine-T method. Kinetic biodistribution studies were done in male CD-1 mice by tail vein injection of 3.7 MBq (100 muCi) of the C-11-labeled radiotracer or 0.67 MBq (2 muCi) of the I-125-labeled radiotracer followed by brain dissection and tissue counting. Receptor blockade was determined by pretreatment of the mice with an excess of either unlabeled precursor or nicotine. Results: We synthesized 4 radiolabeled, moderate- to high-affinity, mu(7)-nAChR-based ligands. The compounds were a series of quinuclidine derivatives with an inhibition constant (K-i) < 6 nmol/L (33 pmol/L for 4) for alpha(7)-nAChR and selectivities of alpha(7)/alpha(4)beta(2) subtypes of greater than or equal to 14,000. All of the compounds were produced in adequate radiochemical yield and specific radioactivity (>74 GBq/mumol [2,000 Ci/mmol]). No site selectivity or receptor blockade was shown for 1 and 2 (0.91 +/- 0.05 and 0.14 +/- 0.03 %ID/g [percentage injected dose per gram] in the hippocampus [target tissue], respectively). Compound 3 showed low hippocampal uptake (0.25 +/- 0.05 %ID/g) but prolonged retention within that structure. Pretreatment with nicotine decreased its uptake by up to 50% in the hippocampus. Similar reductions were also observed within the cerebellum (nontarget tissue). Compound 4 showed hippocampal uptake of 2.41 +/- 0.03 %ID/g and target-to-nontarget uptake ratios of up to 2. Pretreatment of animals with unlabeled 4 resulted in a decrease of hippocampal uptake to 60% of its preblockade value without a corresponding decrease in cerebellar uptake. Conclusion: With further structural optimization, selective imaging of a7-nAChR may be possible.

Pharmacological Characterization of [125I]CHIBA-1006 Binding, a New Radioligand for Α7 Nicotinic Acetylcholine Receptors, to Rat Brain Membranes

Study on Chiba-1001 As A Novel Radioligand for Alpha 7 Nicotinic Acetylcholine Receptors

Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands.

Radiosynthesis and In-Vivo Evaluation of [125I]IBT

Design and Synthesis of New Agents for Neuronal Nicotinic Acetylcholine Receptor (nachrs) Imaging.

Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.

Radioiodinated 9-Fluorenone Derivatives for Imaging Α7-Nicotinic Acetylcholine Receptors.

Synthesis and Biological Evaluation of 9-Fluorenone Derivatives for SPECT Imaging of Α7-Nicotinic Acetylcholine Receptor

Identification and in Vitro Pharmacological Characterization of a Novel and Selective Α7 Nicotinic Acetylcholine Receptor Agonist, Br-IQ17B

Design, Synthesis and Biological Evaluation of 1,4-Diazobicylco[3.2.2]nonane Derivatives As Α7-Nicotinic Acetylcholine Receptor PET/CT Imaging Agents and Agonists for Alzheimer's Disease.

[ 125/123 I] 5-Iodo-3-pyridyl Ethers

Radio Synthesis and in Vivo Evaluation of Two Α7 Nachrs Radioligands: [125I]CAIPE and [125I]IPPU

Novel Pyridyl Ring C5 Substituted Analogues Of 3-(1-Methyl-2(S)- Pyrrolidinylmethoxy)Pyridine (A-84543) As Highly Selective Agents For Neuronal Nicotinic Acetylcholine Receptor(Nachr)

Correction to "development of 11C-Labeled ASEM Analogues for Detection of Neuronal Nicotinic Acetylcholine Receptors (Α7-Nachr)".

Engineered Conotoxin Differentially Blocks and Discriminates Rat and Human α7 Nicotinic Acetylcholine Receptors

Radiosynthesis and ex vivo evaluation of [11C]-SIB-1553A as a PET radiotracer for beta4 selective subtype nicotinic acetylcholine receptor

Fluorescent α-Conotoxin [Q1G, ΔR14]LvIB Identifies the Distribution of α7 Nicotinic Acetylcholine Receptor in the Rat Brain

Neural Nachrs PET Imaging Probes

(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors

[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors

Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261